XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
Preferred Stock [Member]
Series 1 Preferred Stock [Member]
Preferred Stock [Member]
Series C Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Treasury Stock, Preferred [Member]
AOCI Attributable to Parent [Member]
Total
Noncontrolling Interest [Member]
Balance at Sep. 30, 2023 $ 2,293 $ 50 $ 1 $ 68,882,750 $ (64,125,895) $ (148,291) $ 3,076,706 $ 7,687,614 $ 656,179
Balance, shares at Sep. 30, 2023 2,293,016 50,000 498            
Foreign currency translation gain             227,764 227,764  
Share-based compensation       7,557       7,557  
Dividends paid in Series 1 preferred shares $ 115     (115)        
Dividends paid in Series 1 preferred shares, shares 115,037                
Income/(loss) attributable to noncontrolling interest               (96,409)
Net loss       (1,207,494)   (1,207,494)  
Shares issued to pay notes payable       40,000       40,000  
Shares issued to pay notes payable, shares     5            
Balance at Dec. 31, 2023 $ 2,408 $ 50 $ 1 68,930,192 (65,333,389) (148,291) 3,304,470 6,755,441 559,770
Balance, shares at Dec. 31, 2023 2,408,053 50,000 503            
Balance at Sep. 30, 2023 $ 2,293 $ 50 $ 1 68,882,750 (64,125,895) (148,291) 3,076,706 7,687,614 656,179
Balance, shares at Sep. 30, 2023 2,293,016 50,000 498            
Net loss               (5,269,745)  
Balance at Sep. 30, 2024 $ 2,457 $ 50 $ 14 73,262,536 (71,355,386) (148,291) 2,949,297 4,710,677 250,165
Balance, shares at Sep. 30, 2024 2,456,827 50,000 14,176            
Foreign currency translation gain             (131,439) (131,439)  
Share-based compensation       4,087       4,087  
Dividends paid in Series 1 preferred shares $ 123     (123)        
Dividends paid in Series 1 preferred shares, shares 123,167                
Exercise of Series A warrants     $ 1,437 21,514,340       21,515,777  
Exercise of Series A warrants, shares     1,436,749            
Exercise of Series B warrants     $ 334 1,095,397       1,095,731  
Exercise of Series B warrants, shares     333,650            
Income/(loss) attributable to noncontrolling interest                 (180,152)
Net loss       (28,754,367)   (28,754,367)  
Balance at Dec. 31, 2024 $ 2,580 $ 50 $ 1,785 $ 95,876,237 $ (100,109,753) $ (148,291) $ 2,817,858 $ (1,559,534) $ 70,013
Balance, shares at Dec. 31, 2024 2,579,994 50,000 1,784,575